These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 33891518)

  • 1. Public Health Crises In Comparison: China's Epidemic Response Policies From SARS To COVID-19.
    Li M
    Glob Public Health; 2021; 16(8-9):1223-1236. PubMed ID: 33891518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. China's model to combat the COVID-19 epidemic: a public health emergency governance approach.
    Ning Y; Ren R; Nkengurutse G
    Glob Health Res Policy; 2020; 5():34. PubMed ID: 32685691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. China's Public Health Policies in Response to COVID-19: From an "Authoritarian" Perspective.
    Gao J; Zhang P
    Front Public Health; 2021; 9():756677. PubMed ID: 34976920
    [No Abstract]   [Full Text] [Related]  

  • 4. How China controls the Covid-19 epidemic through public health expenditure and policy?
    Jin H; Li B; Jakovljevic M
    J Med Econ; 2022; 25(1):437-449. PubMed ID: 35289700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development, Status Quo, and Challenges to China's Health Informatization During COVID-19: Evaluation and Recommendations.
    Huang M; Wang J; Nicholas S; Maitland E; Guo Z
    J Med Internet Res; 2021 Jun; 23(6):e27345. PubMed ID: 34061761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From SARS to Avian Influenza: The Role of International Factors in China's Approach to Infectious Disease Control.
    Goldizen FC
    Ann Glob Health; 2016; 82(1):180-8. PubMed ID: 27325075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights from the comparisons of SARS-CoV and COVID-19 outbreaks: The evidence-based experience of epidemic prevention in China.
    Liu WY; Chuang YC; Liu TJ; Chien CW; Tung TH
    Medicine (Baltimore); 2021 Feb; 100(6):e24650. PubMed ID: 33578592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention and control mechanism for coronavirus disease 2019 epidemic at the primary level: perspective from China.
    Zhang X; Wang Y
    Epidemiol Infect; 2020 Jul; 148():e161. PubMed ID: 32713366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. China's "dynamic clearing" epidemic prevention policy: Achievements, challenges, and prospects.
    Wang Q; Huang L
    Front Public Health; 2022; 10():978944. PubMed ID: 36187631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of China's COVID-19 prevention and control efforts on outbreaks of influenza.
    Li Q; Wang J; Lv H; Lu H
    Biosci Trends; 2021 Jul; 15(3):192-195. PubMed ID: 34176827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study on the Experience of Public Health System Construction in China's COVID-19 Prevention.
    Zhang P
    Front Public Health; 2021; 9():610824. PubMed ID: 33981659
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of China's public health system response to COVID-19.
    Zhang P; Gao J
    J Glob Health; 2021 Jan; 11():05004. PubMed ID: 33643637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. China's response to a novel coronavirus stands in stark contrast to the 2002 SARS outbreak response.
    Nkengasong J
    Nat Med; 2020 Mar; 26(3):310-311. PubMed ID: 31988464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of China's Hubei control strategy for COVID-19 epidemic: an observational study.
    Liu Y; Zheng F; Du Z; Li J; Gu J; Jiang M; Yoneoka D; Gilmour S; Hao Y
    BMC Infect Dis; 2021 Aug; 21(1):820. PubMed ID: 34399697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appraisal of China's Response to the Outbreak of COVID-19 in Comparison With SARS.
    Li J; Li S; Cao W; Wang Z; Liang Z; Fu W; Zhao J
    Front Public Health; 2021; 9():679540. PubMed ID: 34307279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is Exposure to Epidemic Associated With Older Adults' Health Behavior? Evidence From China's 2002-2004 SARS Outbreak.
    Zou H; Wen S; Xu H
    J Gerontol B Psychol Sci Soc Sci; 2021 Aug; 76(7):e300-e305. PubMed ID: 32827210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geographical tracking and mapping of coronavirus disease COVID-19/severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic and associated events around the world: how 21st century GIS technologies are supporting the global fight against outbreaks and epidemics.
    Kamel Boulos MN; Geraghty EM
    Int J Health Geogr; 2020 Mar; 19(1):8. PubMed ID: 32160889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pains and Gains from China's Experiences with Emerging Epidemics: From SARS to H7N9.
    Wei P; Cai Z; Hua J; Yu W; Chen J; Kang K; Qiu C; Ye L; Hu J; Ji K
    Biomed Res Int; 2016; 2016():5717108. PubMed ID: 27525272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous focus on COVID-19 epidemic: Changes in China's clinical guidance.
    Wang QC; Wang ZY
    Int J Clin Pract; 2021 Mar; 75(3):e13869. PubMed ID: 33264484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reflection and Foresight on Personal Information Protection and Optimization in Public Health Emergencies in China-From the Perspective of Personal Information Collection during the Period of China's Dynamic-Zero COVID-19 Prevention and Control Policy.
    Wang H
    Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36674045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.